Anzeige
Mehr »
Login
Dienstag, 19.03.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Der Zug verlässt den Bahnhof - Umringt von potenziellen Käufern
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
24 Leser
Artikel bewerten:
(0)

Innovative Therapies Inc (ITI) Announces New Executive Management Team of the Wound Care Therapy Division and New User Friendly Website

GAITHERSBURG, Md., Feb. 26,2013 /PRNewswire/ -- Innovative Therapies Inc (ITI) announced today it has launched a new website (www.itimedical.com) and appointed a new executive management team for the negative pressure wound therapy division.

Richard Vogel, CEO, founded ITI in 2006 and has served as ITI's full-time President and CEO since 2008. Richard has held CEO/President/COO and General Manager positions at several medical device, pharmaceutical, and biotech companies such as Kinetic Concepts, Inc. and American Cyanamid Company.

Dave Tumey, Chief Technology Officer (CTO), has 24 years experience in the field of biomedical R&D,including Director of V.A.C. R&D at Kinetic Concepts Inc. (KCI). Dave hasfifty-four issuedpatents with many others pending,and has abackground inelectricalengineering.

Matt Dambeck, Chief Operating Officer (COO), recently joined Innovative Therapies from Stryker and is responsible for operations, sales and clinical service delivery. He has 10 years' experience in the medical device industry, most recently as an Area Director of Sales.

Sandra Berriman, Ph.D., Vice President of Medical Affairs, has over 18yearsexperiencein advancing pharmaceutical and medical deviceentitiesinto the healthcare marketplace. While at Pfizer, her clinical teamdevelopedandlaunchedToviaz, as well as scientificallysupported Detrol LA and Viagra.

Christine Grogan, Vice President of Marketing, has over 20 years ofhealthcare experience in medical and consumermarketing,sales, sales training and management at Allergan, Pfizer, and Parke Davis. She has heldkey leadershiproles as Director of Botox and Senior Director of Breast Implants at Allergan. Christine stated that this new website would be invaluable to health care providers in the wound care space as well as for patients looking for more information about the benefits of negative pressure wound therapy.

Richard Vogel statedthat"This newly appointed executive teamhas vastexperience in launchingblockbustermedicalproducts,and is committed to ensuring that patients in the wound care spaceget the best therapy that this field can offer."

SOURCE Innovative Therapies Inc

Video-Workshop: Das kleine Einmaleins der Charttechnik
In diesem kostenlosen Video-Workshop von Stefan Klotter lernen Sie alles über Charttechnik. Lassen Sie sich diesen kostenfreien Workshop nicht entgehen!
Hier klicken
© 2013 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.